http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114882940-B

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16B15-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16B15-30
filingDate 2022-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-114882940-B
titleOfInvention A method and device for molecular docking based on coherent Ising machine
abstract The invention relates to a molecular docking method and device based on a coherent Ising machine, belongs to the technical field of drug design, and solves the problems that traditional heuristic algorithms may consume a long time but cannot obtain standard solutions. The method includes: constructing a three-dimensional molecular structure map based on selected drug molecules to obtain a ligand map; constructing a pseudo-atom dot map inside a receptor target based on a selected receptor molecule to obtain a receptor map; Construct a ligand-receptor similarity graph, including multiple vertices and multiple edges between any two vertices, any vertex in the multiple vertices includes the points of the ligand graph and the points of the receptor graph, and determine whether each edge is Exist; construct a pharmacophore model based on the ligand-receptor similarity graph to determine whether the selected drug molecule inhibits the activity of the selected receptor, the pharmacophore model calculates the maximum weight group between the selected drug molecule and the selected receptor as Screening out drug molecule compounds. The pharmacophore model solves molecular simulation problems more quickly and accurately.
priorityDate 2022-03-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017139044-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11594
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10907
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419521664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID65028
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558502
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419586922
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224

Total number of triples: 21.